Moderna, Bird Flu

Bird Flu: Vaccines May Drive Virus Evolution
"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers wrote.
U.S. Gives Moderna $590 Million to Accelerate a Bird Flu Vaccine
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Bird Flu: US Invests $590 Million to Fast-Track Vaccine Development
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains with pandemic potential.
Bird flu vaccine: What to know
Medical experts advise that people should get a vaccine for the bird flu when it becomes commercially available. One doctor said the most at-risk patients should be first.
Moderna Awarded $590 Million for Bird Flu Vaccine Development
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.
Moderna Stock Jumps as Biotech Gets $590M From US To Develop Bird-Flu Vaccine
Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023.
Moderna gets $590M from US government for bird flu vaccine
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats. Others, including GSK and Pfizer, are also at work on similar shots.
No need to provide an avian flu vaccine for humans yet, expert says
An infectious disease expert says the relatively mild cases of avian influenza detected so far among dairy workers don’t ...
As avian influenza A(H5N1) concerns continue, mRNA vaccines offer great potential
With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...
Medscape7d
Seasonal Flu Shot: First Defense Against an Eventful Avian Influenza Pandemic
Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger ...